Which of the following is not done in W.P.W?
Wolff-Parkinson-White is a pre-excitation syndrome where an accessory pathway allows abnormal conduction, leading to arrhythmias like SVT. The main concern is avoiding medications that can accelerate conduction through the accessory pathway, especially during atrial fibrillation, which can lead to ventricular fibrillation.
Common treatments include medications that block the AV node, like calcium channel blockers (verapamil), beta-blockers, and digoxin. However, these are contraindicated in certain scenarios. For example, digoxin shouldn't be used if there's a risk of accelerating conduction through the accessory pathway. Also, certain antiarrhythmics like procainamide or amiodarone might be used in specific situations.
Wait, the question is about what is NOT done in W.P.W. So the incorrect options might include using verapamil in acute SVT, but actually, in acute SVT with WPW, the first line is vagal maneuvers or adenosine. Verapamil is contraindicated in WPW with atrial fibrillation because it can increase the risk of ventricular fibrillation. So if an option suggests using verapamil in such a case, that's the correct answer here.
Looking at the options, if one of them is using verapamil in atrial fibrillation with WPW, that's the answer. Alternatively, maybe another drug like digoxin in acute settings. Let me check the standard guidelines. Yes, in WPW with atrial fibrillation, you avoid AV nodal blockers because they can increase the conduction via the accessory pathway. So verapamil, beta-blockers, digoxin are all contraindicated in atrial fibrillation with WPW. But in acute SVT, adenosine is preferred. So if an option suggests using verapamil for acute SVT in WPW, that's incorrect.
The correct answer would be an option that recommends using a medication that's contraindicated. So the explanation needs to highlight that. Also, the clinical pearl would be to avoid AV nodal blockers in WPW with atrial fibrillation. So the correct answer is the one that says using verapamil in that scenario.
**Core Concept**
Wolff-Parkinson-White (WPW) syndrome involves an accessory pathway (bundle of Kent) that bypasses the AV node, enabling rapid ventricular conduction. Key management principles focus on avoiding medications that enhance conduction through this pathway, especially in atrial fibrillation, to prevent life-threatening ventricular arrhythmias.
**Why the Correct Answer is Right**
In WPW with atrial fibrillation, **AV nodal blockers** (e.g., verapamil, digoxin, beta-blockers) are contraindicated. These drugs slow AV nodal conduction but paradoxically accelerate conduction via the accessory pathway, increasing the risk of ventricular fibrillation. The correct answer identifies a prohibited intervention in this context.
**Why Each Wrong Option is Incorrect**
**Option A:** *